IMMUNOHISTOCHEMISTRY, CD 4

The IHC – CD4 (Cluster of Differentiation 4) test is an immunohistochemistry-based diagnostic assay used to detect CD4 protein expression in tissue samples. CD4 is a surface glycoprotein primarily expressed on helper T lymphocytes (T-helper cells) and plays a critical role in regulating immune system responses.

This test is widely used in hematopathology and oncology to identify T-cell lineage, classify lymphoid malignancies, and evaluate immune cell populations within tissue samples. CD4 staining helps pathologists distinguish different types of lymphomas and assess immune-related conditions.

Benefits of the Test

• Helps identify helper T-cell populations
• Assists in diagnosing T-cell lymphomas
• Supports classification of lymphoid malignancies
• Improves accuracy in immunophenotyping
• Helps guide treatment planning and prognosis evaluation

Why Doctors Recommend This Test

Doctors recommend the IHC CD4 test when there is suspicion of T-cell lymphoma, lymphoproliferative disorders, or immune-related diseases. It is commonly used in:

• Diagnosis of peripheral T-cell lymphoma
• Evaluation of lymph node biopsies
• Classification of lymphoid neoplasms
• Assessment of cutaneous T-cell lymphoma
• Hematopathology investigations

CD4 is often evaluated alongside other markers such as CD3, CD5, CD8, CD20, and Ki-67 to establish the immunophenotype of abnormal lymphoid cells and achieve an accurate diagnosis.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting or medication restrictions are necessary
• Previous pathology reports and clinical history may aid interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on specimen complexity and laboratory workflow.

Who Should Take This Test

• Patients with suspected T-cell lymphoma
• Individuals with persistent lymph node enlargement
• Cases requiring lymphoid tumor classification
• Patients undergoing biopsy evaluation for hematological malignancies
• Oncology patients requiring immunohistochemistry profiling

The IHC CD4 test is an important diagnostic tool in hematopathology. By identifying helper T-cell populations and T-cell lineage, it helps pathologists accurately classify lymphoid malignancies and support effective treatment planning.